SONNET BIOTHERAPEUTICS HOLDINGS, INC. Research and Development in Process
SONNET BIOTHERAPEUTICS HOLDINGS, INC. reported Research and Development in Process of $100.00 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-02-13
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for the quarter ending 2022-12-31 was $100.00K, a 16.67% decline year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for the quarter ending 2022-09-30 was $99.60K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for the quarter ending 2022-06-30 was $586.25K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for the quarter ending 2022-03-31 was $165.63K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for fiscal 2022 was $971.48K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development in process for fiscal 2020 was $6.83M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $100.00K 10-Q · filed 2023-02-13 | $199.60K derived: sum of 2 quarters · filed 2023-02-13 | $785.85K derived: sum of 3 quarters · filed 2023-02-13 | $951.48K derived: sum of 4 quarters · filed 2023-02-13 |
| 2022-09-30 | $99.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-15 | $685.85K derived: sum of 2 quarters · filed 2022-12-15 | $851.48K derived: sum of 3 quarters · filed 2022-12-15 | $971.48K 10-K · filed 2022-12-15 |
| 2022-06-30 | $586.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $751.88K derived: sum of 2 quarters · filed 2022-08-15 | $871.88K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $165.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $285.63K 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $120.00K 10-Q · filed 2023-02-13 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-17 | $6.83M derived: sum of 2 quarters · filed 2021-12-17 | $6.83M 10-K · filed 2021-12-17 | |
| 2020-06-30 | $6.83M 10-Q · filed 2021-08-16 | $6.83M 10-Q · filed 2021-08-16 |